BioLife Solutions, a key player in bioproduction for cell and gene therapy, announced it will release its first quarter 2026 financial results on May 7, 2026. The company will host a conference call and live webcast at 4:30pm ET to discuss the results and provide a business update. Investors can access the webcast via the company's website or by phone, with a replay available for 90 days. This event is important for stakeholders to assess BioLife's financial health and progress in the growing biopharma market.
The global automotive microcontrollers market is projected to grow from USD 15.49 billion in 2025 to USD 34.31 billion by 2035, at a CAGR of 8.28%. Growth is fueled by increasing adoption of advanced driver-assistance systems (ADAS), vehicle electrif...
UnitedHealth Group reported second-quarter earnings that surpassed expectations, driven by better management of high medical costs and AI investments to streamline operations. The company raised its 2026 adjusted earnings forecast to $19.50-$20 per s...
Meta Platforms has been upgraded to a buy rating due to its new cloud business, which is expected to stabilize cash flow and improve profitability. Despite heavy capital expenditures, Meta maintains strong free cash flow margins and operational effic...
SpaceX shares fell below their IPO price of $135 for the first time, dropping to $132.28 before closing slightly above at $135.27. The stock is down about 16% from its June 12 closing price and 36% from its peak on June 16. The decline reflects inves...
Aave has deployed its latest V4 lending protocol on the Avalanche blockchain, marking the first time this version runs outside Ethereum. This launch extends Aave's new Hub and Spoke architecture to Avalanche, where older V3 markets already exist. Whi...
